Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
C-(1-hydrogyl-beta-D-glucopyranosyl) formamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
C-(1-hydrogyl-beta-D-glucopyranosyl) formamide is a synthetic small molecule classified as a c-glycosyl compound. It consists of a glucopyranose sugar moiety covalently linked to a formamide group. The compound has been studied experimentally and is not approved for clinical use in any country. Its primary mechanism of action is the inhibition of glycogen phosphorylase (muscle form), an enzyme involved in glycogen breakdown. This suggests potential utility in modulating glucose metabolism or as a research tool for studying carbohydrate metabolism[1][2][5]. No approved indications or marketed products are associated with this molecule.
- Other names
- (2R,3R,4S,5S,6R)-2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxane-2-carboxamide(2R,3R,4S,5S,6R)-2,3,4,5-tetrahydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-carboxamidealpha-D-gluco-2-Heptulopyranosonamidealpha-D-gluco2-Heptulopyranosonamidealpha-D-gluco 2-Heptulopyranosonamide(1-Hydroxy-beta-D-glucopyranosyl)formamide
02
Targets
PYGM (Glycogen phosphorylase, muscle form)
Beyond the preview
Go deeper on C-(1-hydrogyl-beta-D-glucopyranosyl) formamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on C-(1-hydrogyl-beta-D-glucopyranosyl) formamide.